Engineers Gate Manager’s Catalyst Pharmaceutical CPRX Stock Holding History

Engineers Gate Manager’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.66M	Buy	67,061 +18,922	+39%	+$451K	0.02%	797
2025 Q4	$1.12M	Sell	48,139 -95,525	-66%	-$2.13M	0.01%	972
2025 Q3	$2.83M	Buy	143,664 +87,522	+156%	+$1.8M	0.03%	601
2025 Q2	$1.22M	Buy	+56,142	New	+$1.33M	0.02%	1017
2025 Q1	–	Sell	-42,737	Closed	-$892K	–	2222
2024 Q4	$892K	Sell	42,737 -4,159	-9%	-$89.3K	0.02%	1081
2024 Q3	$932K	Sell	46,896 -39,652	-46%	-$735K	0.02%	1035
2024 Q2	$1.34M	Sell	86,548 -60,407	-41%	-$940K	0.03%	750
2024 Q1	$2.34M	Buy	+146,955	New	+$2.21M	0.06%	421
2023 Q4	–	Sell	-102,731	Closed	-$1.2M	–	2012
2023 Q3	$1.2M	Buy	+102,731	New	+$1.37M	0.04%	600
2023 Q2	–	Sell	-26,011	Closed	-$431K	–	1781
2023 Q1	$431K	Buy	+26,011	New	+$429K	0.02%	1052
2022 Q4	–	Sell	-38,274	Closed	-$491K	–	1724
2022 Q3	$491K	Sell	38,274 -21,965	-36%	-$260K	0.03%	822
2022 Q2	$422K	Buy	60,239 +18,794	+45%	+$138K	0.02%	1205
2022 Q1	$344K	Buy	+41,445	New	+$293K	0.01%	1301
2021 Q4	–	Sell	-15,395	Closed	-$82K	–	2052
2021 Q3	$82K	Sell	15,395 -30,708	-67%	-$168K	﹤0.01%	1553
2021 Q2	$265K	Sell	46,103 -9,963	-18%	-$51.4K	0.02%	1218
2021 Q1	$258K	Buy	56,066 +42,870	+325%	+$170K	0.01%	1418
2020 Q4	$44K	Sell	13,196 -208,162	-94%	-$699K	﹤0.01%	1640
2020 Q3	$657K	Buy	+221,358	New	+$866K	0.03%	842
2015 Q2	–	Sell	-14,882	Closed	-$64K	–	1044
2015 Q1	$64K	Buy	+14,882	New	+$53.6K	0.01%	903

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Engineers Gate Manager's CPRX Position: Q1 2026 in Review

Engineers Gate Manager increased its Catalyst Pharmaceutical (CPRX) stake by 39% in Q1 2026, buying an estimated $451K and bringing the position to 67,061 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #797.

Engineers Gate Manager first reported a position in CPRX in Q1 2015 and has held it in 19 quarters since. The position peaked at $2.83M in Q3 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Engineers Gate Manager held 67,061 shares of Catalyst Pharmaceutical worth $1.66M as of Q1 2026.
Engineers Gate Manager bought 18,922 Catalyst Pharmaceutical shares in Q1 2026, an estimated $451K.
Catalyst Pharmaceutical made up 0.02% of Engineers Gate Manager's portfolio in Q1 2026, its #797 holding.
Engineers Gate Manager first reported a position in Catalyst Pharmaceutical in Q1 2015 and has held it in 19 quarters since.
Engineers Gate Manager's Catalyst Pharmaceutical position peaked at $2.83M in Q3 2025.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.